The KIF5B-RET Fusion as a Novel Mechanism of Acquired EGFR Tyrosine Kinase Inhibitor Resistance in Lung Adenocarcinoma

被引：0

作者：

Zhu, Y. ^{[1
]}

Wang, W. ^{[2
]}

Xu, C. ^{[3
]}

Zhang, Q. ^{[4
]}

Zhuang, W. ^{[3
]}

Du, K. ^{[1
]}

Chen, G. ^{[4
]}

Fang, M. ^{[2
]}

Lv, T. ^{[5
]}

Song, Y. ^{[5
]}

机构：

[1] Zhejiang Rongjun Hosp, Thorac Dis Ctr, Jiaxing, Peoples R China

[2] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China

[3] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China

[4] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China

[5] Jinling Hosp, Nanjing, Jiangsu, Peoples R China

来源：

关键词：

Epidermal growth factor receptor; Non-Small Cell Lung Cancer; icotinib;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP1.14-46

引用

页码：S1049 / S1049

页数：1